1. A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma
- Author
-
Jianming Li, Yuan Zu, Linxue Qian, Peipei Yang, Yujiang Liu, and Junfeng Zhao
- Subjects
Cancer Research ,medicine.medical_specialty ,complications ,Physiology ,medicine.medical_treatment ,Metastasis ,Cohort Studies ,Lesion ,Physiology (medical) ,Medical technology ,medicine ,Humans ,papillary thyroid microcarcinoma ,Thyroid Neoplasms ,R855-855.5 ,Microwaves ,Retrospective Studies ,thyroid gland ,business.industry ,Incidence (epidemiology) ,Microwave ablation ,Thyroidectomy ,medicine.disease ,Ablation ,Carcinoma, Papillary ,Surgery ,Treatment Outcome ,Hypoparathyroidism ,microwave ablation ,thyroidectomy ,medicine.symptom ,business ,Cohort study - Abstract
Background The optimal treatment method for papillary thyroid microcarcinoma (PTMC) is lacking consensus. Here we aimed to compare the efficacy and safety of surgery and microwave ablation (MWA) for PTMC. Methods The clinical data of 644 patients with PTMC treated between July 2013 and June 2020 were retrospectively analyzed. A total of 320 and 324 patients underwent MWA and surgery, respectively. We observed lesion changes in the MWA group and compared the recurrence, metastasis, complications, and other health economic indicators between the 2 groups. Results The mean follow-up time was 890.7 ± 532.9 (187.9–2679.0) days in the MWA group and 910.9 ± 568.4 (193.8–2821.5) days in the surgery group. In the MWA group, lesion volume increased significantly after ablation and then gradually decreased. The final lesion volume reduction rate was 90.73% ± 7.94%, and 193 lesions (60.3%) disappeared completely. There were no significant intergroup differences in recurrence or metastasis. The incidence of main complications (temporary hypothyroidism, hypoparathyroidism, and temporary hoarseness) was significantly lower in the MWA group than in the surgery group (p
- Published
- 2021
- Full Text
- View/download PDF